(MedPage Today) -- Patients with Cushing's disease treated with the somatostatin analog pasireotide (Signifor) had improvements in multiple manifestations of hypercortisolism, even if urinary free cortisol levels were incompletely controlled, a study found. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment